Adding TAR-200 to neoadjuvant cetrelimab improved the pCR rate in patients with muscle-invasive bladder cancer in a phase 2 trial.

Aldosterone increases blood pressure and contributes to chronic kidney disease (CKD) progression. Trial findings suggest baxdrostat may be an effective treatment.

Anrikefon is a kappa opioid receptor agonist with enhanced affinity for the receptor and minimal penetration of the blood-brain barrier.